The diagnostic accuracy of the MyDiagnostick to detect atrial fibrillation in primary care

Bert Vaes, Silke Stalpaert, Karen Tavernier, Britt Thaels, Daphne Lapeire, Wilfried Mullens, Jan Degryse, Bert Vaes, Silke Stalpaert, Karen Tavernier, Britt Thaels, Daphne Lapeire, Wilfried Mullens, Jan Degryse

Abstract

Background: Atrial fibrillation is very common in people aged 65 or older. This condition increases the risk of death, congestive heart failure and thromboembolic conditions. Many patients with atrial fibrillation are asymptomatic and a cerebrovascular accident (CVA) is often the first clinical presentation. Guidelines concerning the prevention of CVA recommend monitoring the heart rate in patients aged 65 or older. Recently, the MyDiagnostick (Applied Biomedical Systems BV, Maastricht, The Netherlands) was introduced as a new screening tool which might serve as an alternative for the less accurate pulse palpation. This study was designed to explore the diagnostic accuracy of the MyDiagnostick for the detection of atrial fibrillation.

Methods: A phase II diagnostic accuracy study in a convenience sample of 191 subjects recruited in primary care. The majority of participants were patients with a known history of atrial fibrillation (n=161). Readings of the MyDiagnostick were compared with electrocardiographic recordings. Sensitivity and specificity and their 95% confidence interval were calculated using 2x2 tables.

Results: A prevalence of 54% for an atrial fibrillation rhythm was found in the study population at the moment of the study. A combination of three measurements with the MyDiagnostick for each patient showed a sensitivity of 94% (95% CI 87 - 98) and a specificity of 93% (95% CI 85 - 97).

Conclusion: The MyDiagnostick is an easy-to-use device that showed a good diagnostic accuracy with a high sensitivity and specificity for atrial fibrillation in a convenience sample in primary care. Future research is needed to determine the place of the MyDiagnostick in possible screening or case-finding strategies for atrial fibrillation.

Figures

Figure 1
Figure 1
The MyDiagnostick device.
Figure 2
Figure 2
Single-lead ECGs provided by the MyDiagnostick (sinus rhythm and atrial fibrillation).
Figure 3
Figure 3
Flow chart of study participants.

References

    1. Pérula-de-Torres LA, Martínez-Adell MA, González-Blanco M, Baena-Díez JM, Martín-Rioboó E, Parras-Rejano JM, González-Lama J, Martín-Alvarez R, Ruiz-Moral R, Fernández-García JÁ, Pérez-Díaz M, Ruiz-de-Castroviejo J, Pérula-de-Torres C, Valero-Martín A, Roldán-Villalobos A, Criado-Larumbe M, Burdoy-Joaquín E, Coma-Solé M, Cervera-León M, Cuixart-Costa L. Collaborative Group DOFA-AP. Opportunistic detection of atrial fibrillation in subjects aged 65 years or older in primary care: a randomised clinical trial of efficacy. DOFA-AP study protocol. BMC Fam Pract. 2012;13:13–106. doi: 10.1186/1471-2296-13-13.
    1. Miyasake Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Seward JB, Iwasaka T, Tsang TS. Coronary ischemic events after first atrial fibrillation: risk and survival. Am J Med. 2007;120:357–363. doi: 10.1016/j.amjmed.2006.06.042.
    1. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D'Agostino RB, Murabito JM, Kannel WB, Benjamin EJ. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107:2920–2925. doi: 10.1161/01.CIR.0000072767.89944.6E.
    1. Morgan S, Mant D. Randomised trial of two approaches to screening for atrial fibrillation in UK general practice. Br J Gen Pract. 2002;373:380.
    1. Markides V, Schilling RJ. Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment. Heart. 2003;89:939–943. doi: 10.1136/heart.89.8.939.
    1. Camm J, Lip G, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P. ESC Committee for Practice Guidelines(CPG) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. Eur Heart J. 2012;33:2719–2747.
    1. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285:2864–2870. doi: 10.1001/jama.285.22.2864.
    1. Lip G, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk facto-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest. 2010;137:263–272. doi: 10.1378/chest.09-1584.
    1. Wilson JMG, Jungner G. The principles and practice of screening for disease. WHO Public Health papers. Geneva: World Health Organization; 1968.
    1. Nieuwlaat R, Olsson SB, Lip G, Camm AJ, Breithardt G, Capucci A, Meeder JG, Prins MH, Lévy S, Crijns HJ. Euro Heart Survey Investigators. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation: the Euro heart Survey on Atrial Fibrillation. Am Heart J. 2007;153:1006–1012. doi: 10.1016/j.ahj.2007.03.008.
    1. Harris K, Edwards D, Mant J. How can we best detect atrial fibrillation? J R Coll Physicians Edinb. 2012;42(suppl 18):5–22.
    1. MyDiagnostick. .
    1. Carley S, Dosman S, Jones SR, Harrison M. Simple nomograms to calculate sample size in diagnostic studies. Emerg Med J. 2005;22:180–181. doi: 10.1136/emj.2003.011148.
    1. Prineas R, Crow R, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. John Wright – PSG, Inc: Littleton MA; 1982.
    1. Wiesel J, Abraham S, Messineo FC. Screening for asymptomatic atrial fibrillation while monitoring the blood pressure at home: trial of regular versus irregular pulse for prevention of stroke (TRIPPS 2.0) Am J Cardiol. 2013;111:1598–1601. doi: 10.1016/j.amjcard.2013.01.331.
    1. Wiesel J, Fitzig L, Herschman Y, Messineo FC. Detection of atrial fibrillation using a modified microlife blood pressure monitor. Am J Hypertens. 2009;22:848–852. doi: 10.1038/ajh.2009.98.
    1. Somerville S, Somerville J, Croft P, Lewis M. Atrial fibrillation: a comparison of methods to identify cases in general practice. Br J Gen Pract. 2000;50:727–729.
    1. Lewis M, Parker D, Weston C, Bowes M. Screening for atrial fibrillation: sensitivity and specificity of a new methodology. Br J Gen Pract. 2011;61:38–39. doi: 10.3399/bjgp11X548956.
    1. Mant J, Fitzmaurice DA, Hobbs FD, Jowett S, Murray ET, Holder R, Davies M, Lip GY. Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial. BMJ. 2007;335:380. doi: 10.1136/.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit